Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States
Dr. David E. Kandzari is the Director, Interventional Cardiology and Chief Scientific Officer the Piedmont Heart Institute in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology.
Disclosure information not submitted.
Clinical Evidence and Efficacy of RF RDN
Saturday, March 9, 2024
7:57 PM – 8:12 PM ET
Saturday, March 9, 2024
8:42 PM – 8:57 PM ET
Complex PCI | Session One [Non-CME]
Sunday, March 10, 2024
8:00 AM – 12:02 PM ET
Sunday, March 10, 2024
8:00 AM – 8:45 AM ET
Live Case from Minneapolis VA Medical Center | Minneapolis, MN
Sunday, March 10, 2024
8:00 AM – 8:45 AM ET
Sunday, March 10, 2024
8:45 AM – 9:56 AM ET
Panel Discussion | Who Should Get MCS for High-Risk PCI and with Which Device?
Sunday, March 10, 2024
9:41 AM – 9:56 AM ET
Complex PCI | Session Two [Non-CME]
Sunday, March 10, 2024
2:00 PM – 6:00 PM ET
Renal Denervation and Hypertension Therapies [Non-CME]
Sunday, March 10, 2024
1:30 PM – 5:45 PM ET
From Clinical Trials to Clinical Practice | Symplicity Spyral RDN System
Sunday, March 10, 2024
1:46 PM – 1:54 PM ET
Case-in-a-Box | RECOR Paradise Ultrasound RDN System
Sunday, March 10, 2024
1:54 PM – 2:32 PM ET
Case-in-a-Box | Medtronic Symplicity Spyral Renal Denervation System
Sunday, March 10, 2024
3:12 PM – 3:40 PM ET
Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation
Sunday, March 10, 2024
5:32 PM – 5:45 PM ET